BACKGROUND: Circulating tumor DNA (ctDNA) has emerged as a promising noninvasive biomarker to capture tumor genetics in patients with brain tumors. Research into its clinical utility, however, has not been standardized because the sensitivity and specificity of ctDNA remain undefined. OBJECTIVE: To (1) review the primary literature about ctDNA in adults with glioma to compare the sensitivity and specificity of ctDNA in the cerebrospinal fluid vs the plasma and (2) to evaluate the effect of tumor grade on detection of ctDNA. METHODS: PRISMA-guided systematic review and meta-analysis was performed using published studies that assessed ctDNA in either plasma or cerebrospinal fluid among adult patients with confirmed glioma. Summary receiver operating characteristic curves were generated using the Rücker-Schumacher method, and area under the curve (AUC) was calculated. RESULTS: Meta-analysis revealed improved biomarker performance for CSF (AUC = 0.947) vs plasma (AUC = 0.741) ctDNA, although this did not reach statistical significance (P = .141). Qualitative analysis revealed greater sensitivities among single-allele PCR and small, targeted next-generation sequencing panels compared with broader panels. It additionally demonstrated higher sensitivity of ctDNA detection in high-grade vs low-grade gliomas, although these analyses were limited by a lack of specificity reporting in many studies. CONCLUSION: ctDNA seems to be a highly sensitive and specific noninvasive biomarker among adults with gliomas. To maximize its performance, CSF should be studied with targeted genetic analysis platforms, particularly in high-grade gliomas. Further studies on ctDNA are needed to define its clinical utility in diagnosis, prognostication, glioblastoma pseudoprogression, and other scenarios wherein neoadjuvant therapies may be considered.
Background: There is a concern that glioma patients undergoing repeat craniotomies are more prone to complications. The study’s goal was to assess if the complication profiles for initial and repeat craniotomies were similar, to determine predictors of complications, and to compare results with those in the literature. Methods: A retrospective study was conducted of glioma patients (WHO grade II–IV) who underwent either an initial or repeat craniotomy performed by the senior author from 2012 until 2019. Complications were recorded by discharge, 30 days, and 90 days postoperatively. New neurologic deficits were recorded by 90 days postoperatively. Multivariate regression was performed to identify factors associated with complications. A meta-analysis was performed to identify rates of complications based on number of prior craniotomies. Results: Within the cohort of 714 patients, 400 (56%) had no prior craniotomies, 218 (30.5%) had undergone 1 prior craniotomy, and 96 (13.5%) had undergone ≥ 2 prior craniotomies. There were 27 surgical and 10 medical complications in 30 patients (4.2%) and 19 reoperations for complications in 19 patients (2.7%) with no deaths by 90 days. Complications, reoperation rates, and new neurologic deficits did not differ based on number of prior craniotomies. On multivariate analysis, older age (OR1.5, 95%CI 1.0–2.2) and significant leukocytosis due to steroid use (OR12.6, 95%CI 2.5–62.9) were predictors of complications. Complication rates in the cohort were lower than rates reported in the literature. Conclusion: Contrary to prior reports in the literature, repeat craniotomies can be as safe as initial operations if surgeons implement best practices.
Aneurysmal subarachnoid hemorrhage (SAH) is frequently complicated by permanent shunt-dependent hydrocephalus, but it is difficult to predict which patients are at highest risk. This study seeks to identify novel variables associated with shunt dependency after aneurysmal SAH and to create a predictive algorithm that improves upon existing models. Retrospective case-control design was used. Patients who presented with aneurysmal SAH and external ventricular drain (EVD) placement were included. Those who successfully weaned off their EVD were compared with those who required shunt placement. Demographic and treatment data were analyzed using univariate and multivariable logistic regression. Receiver operating characteristic was used to compare the proposed model's performance against existing ones (Barrow Neurological Institute, chronic hydrocephalus ensuing from SAH score, and shunt dependency in SAH scores). One hundred patients were included: 50 no shunt and 50 shunt. Advanced age, elevated modified Graeb score, intraventricular hemorrhage, increased clot thickness, acute hydrocephalus, and cerebrospinal fluid protein >110 mg/dL prior to wean attempt were all found to be significantly associated with progression to shunt-dependency (P = 0.0351, 0.0022, 0.0407, 0.0274, 0.0014, and 0.0064, respectively). Multivariate regression demonstrated an area under the curve of 0.7852 (P < 0.0001), outperforming those of the other models. Our study suggests that elevated modified Graeb score on initial computed tomography and high cerebrospinal fluid protein levels prior to EVD wean are important prognostic indicators for the development of shunt dependency after aneurysmal SAH. Integrating these findings into clinical practice may aid in earlier and more targeted decision-making.
13 April 2026 in Journal of Neurosurgery: Case Lessons
BACKGROUND: Microvascular decompression (MVD) is a well-established treatment for compressive cranial neuralgias such as trigeminal neuralgia and hemifacial spasm. The vagus nerve (cranial nerve [CN] X), with its extensive parasympathetic innervation to the gastrointestinal (GI) system, has less clearly defined neuropathic symptomatology, and MVD of CN X has only been reported once. The authors report a unique case of treatment-refractory GI distress that resolved completely following CN X MVD. OBSERVATIONS: A 32-year-old male with a 13-year history of hemifacial spasm also experienced chronic, debilitating GI distress characterized by sudden, painful abdominal cramping and diarrhea. Despite extensive workup, including three colonoscopies, no clear etiology was found. During MVD for his facial nerve, a large vertebral artery loop was incidentally found significantly displacing CN X. Both nerves were decompressed. Both the patient’s hemifacial spasms and GI symptoms resolved immediately, and this has persisted for more than 5 years of follow-up. LESSONS: While vagal injury (including intentionally via vagotomy) results in gastroparesis, the authors propose that chronic CN X compression may induce a “hyperactive rhizopathy” resulting in symptoms of overactive peristalsis. CN X compression may be an underrecognized, reversible etiology of chronic GI distress, and clinicians should consider the possibility of neurovascular conflict in this patient population. https://thejns.org/doi/10.3171/CASE2688
Background: Supratotal resection (SpTR) has emerged as a compelling surgical target for gliomas, with a strong signal toward improved survival. However, the balance between resections extending into tumor-infiltrated normal brain and preservation of higher-order cognitive function remains poorly defined. This systematic review aims to characterize formal neuropsychological (NP) outcomes following glioma SpTR. Methods: A PRISMA-adherent systematic search was conducted across six electronic databases. Inclusion criteria required patients with WHO Grade 2-4 gliomas undergoing SpTR with standardized NP assessment. Quality was assessed using the Joanna Briggs Institute (JBI) Critical Appraisal Checklists. Results: Fifty-five studies reported SpTR for glioma, but only 11 (20%) utilized formal NP testing as an outcome. 80% of studies omitting NP testing focused exclusively on high-grade glioma (HGG). Cognitive data was available from 2 studies in HGG and 9 studies in LGG. Early post-operative cognitive declines were reported in 55.5% of extractable cohorts, predominantly in the domains of executive function and memory/learning. The majority of these studies report cognitive recovery after 3-6 months. Long-term permanent cognitive morbidity was indeed very low (∼1%), but critical appraisal revealed a high risk of bias. Conclusions: While current evidence suggests SpTR is functionally safe, these findings are limited by high risk of bias and a lack of comparative controls. A reporting gap remains in functional-cognitive outcomes after HGG surgery. Standardized, anatomically anchored NP testing will be essential to validate the “onco-functional balance” of supratotal margins.